IL137598A - Oral formulations for treatment of chronic inflammatory disorders of the gastrointestinal tract - Google Patents
Oral formulations for treatment of chronic inflammatory disorders of the gastrointestinal tractInfo
- Publication number
- IL137598A IL137598A IL13759898A IL13759898A IL137598A IL 137598 A IL137598 A IL 137598A IL 13759898 A IL13759898 A IL 13759898A IL 13759898 A IL13759898 A IL 13759898A IL 137598 A IL137598 A IL 137598A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- gastrointestinal tract
- chronic inflammatory
- inflammatory disorders
- oral formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/002265 WO1999039699A1 (en) | 1998-02-09 | 1998-02-09 | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL137598A0 IL137598A0 (en) | 2001-07-24 |
| IL137598A true IL137598A (en) | 2005-09-25 |
Family
ID=22266344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13759898A IL137598A (en) | 1998-02-09 | 1998-02-09 | Oral formulations for treatment of chronic inflammatory disorders of the gastrointestinal tract |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1052977A4 (en) |
| JP (1) | JP2002502812A (en) |
| KR (1) | KR20010040646A (en) |
| CN (1) | CN1149078C (en) |
| AU (1) | AU735084B2 (en) |
| CA (1) | CA2320087C (en) |
| IL (1) | IL137598A (en) |
| SE (1) | SE0002831L (en) |
| WO (1) | WO1999039699A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100333727C (en) * | 2004-11-25 | 2007-08-29 | 天津药业研究院有限公司 | Budesonide target-direction microball and preparation thereof |
| MD2852C2 (en) * | 2005-03-28 | 2006-04-30 | Георге АНГЕЛИЧ | Use of budesonide for treatment of resistant ascites to pacients with hepatic cirrhosis |
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| CN101610754A (en) | 2007-02-16 | 2009-12-23 | Aska制药株式会社 | The pharmaceutical composition that contains fine particle oil-based suspension |
| JP2011503073A (en) | 2007-11-13 | 2011-01-27 | メリテイジ ファーマ，インク． | Corticosteroid composition |
| US20090143343A1 (en) | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643602A (en) * | 1989-11-22 | 1997-07-01 | Astra Aktiebolag | Oral composition for the treatment of inflammatory bowel disease |
| HU0004452D0 (en) * | 1991-12-18 | 2001-01-29 | Astra Ab | |
| GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
| GB9409778D0 (en) * | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
| GB9412394D0 (en) * | 1994-06-21 | 1994-08-10 | Danbiosyst Uk | Colonic drug delivery composition |
| KR20000029784A (en) * | 1996-08-02 | 2000-05-25 | 나까도미 히로다카 | Capsules for oral preparations and capsule preparations for oral administration |
| KR100219918B1 (en) * | 1997-07-03 | 1999-09-01 | 김윤 | Composition for colon specific drug delivery |
-
1998
- 1998-02-09 CN CNB988135329A patent/CN1149078C/en not_active Expired - Fee Related
- 1998-02-09 WO PCT/US1998/002265 patent/WO1999039699A1/en not_active Application Discontinuation
- 1998-02-09 IL IL13759898A patent/IL137598A/en not_active IP Right Cessation
- 1998-02-09 EP EP98907382A patent/EP1052977A4/en not_active Withdrawn
- 1998-02-09 KR KR1020007008518A patent/KR20010040646A/en not_active Application Discontinuation
- 1998-02-09 AU AU63200/98A patent/AU735084B2/en not_active Ceased
- 1998-02-09 JP JP2000530199A patent/JP2002502812A/en active Pending
- 1998-02-09 CA CA002320087A patent/CA2320087C/en not_active Expired - Fee Related
-
2000
- 2000-08-07 SE SE0002831A patent/SE0002831L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999039699A1 (en) | 1999-08-12 |
| AU735084B2 (en) | 2001-06-28 |
| KR20010040646A (en) | 2001-05-15 |
| SE0002831L (en) | 2000-09-28 |
| CN1149078C (en) | 2004-05-12 |
| IL137598A0 (en) | 2001-07-24 |
| CA2320087A1 (en) | 1999-08-12 |
| EP1052977A4 (en) | 2006-07-12 |
| JP2002502812A (en) | 2002-01-29 |
| EP1052977A1 (en) | 2000-11-22 |
| CN1284869A (en) | 2001-02-21 |
| CA2320087C (en) | 2006-12-19 |
| AU6320098A (en) | 1999-08-23 |
| SE0002831D0 (en) | 2000-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200401004B (en) | Combination for the treatment of inflammatory disorders | |
| PL351134A1 (en) | Compositions for treatment of disorders of the oesophagus | |
| EP1578385A4 (en) | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders | |
| AU2001271973A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
| AU2001278852A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| PL362711A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
| HRP990195B1 (en) | Intranasal formulations for the treatment of sexual disorders | |
| EP1556010A4 (en) | Pharmaceutical formulations targeting specific regions of the gastrointestinal tract | |
| AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
| IL142908A0 (en) | Compounds useful in the treatment of inflammatory diseases | |
| IL162485A0 (en) | Compounds for the treatment of inflammatory disorders | |
| IL153425A0 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
| HUP0401427A3 (en) | Oral compositions for the treatment of scalp disorders | |
| AU9551298A (en) | Use of coumarin derivatives for the treatment of digestive tract disorders | |
| AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
| HUP9904073A3 (en) | Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid | |
| IL137598A (en) | Oral formulations for treatment of chronic inflammatory disorders of the gastrointestinal tract | |
| GB9825904D0 (en) | Diagnosis of gastric and lung disorders | |
| IL160852A0 (en) | Pharmaceutical compositions for the treatment of urinary disorders | |
| AUPP687298A0 (en) | Herbal compositions for treatment of gastrointestinal disorders | |
| AU8339301A (en) | Compounds for the treatment of addictive disorders | |
| AU2003274885A1 (en) | Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders | |
| HUP9902737A3 (en) | The use of aryl-cyclohexylamine derivatives for preparing pharmaceutical compositions suitable for treatment of cns disorders | |
| AU3582101A (en) | The treatment of functional gastrointestinal disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |